Skip to content

Cerebral Hypoperfusion at Transcranial Color-Coded Doppler.

Cerebral Hypoperfusion at Transcranial Color-Coded Doppler. Effects of a Treatment Protocol in Patients With Acute Brain Injury

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06607211
Acronym
IPOPERT
Enrollment
100
Registered
2024-09-23
Start date
2024-10-01
Completion date
2026-03-31
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Injury

Brief summary

Background. Cerebral ischemia is a major secondary factor contributing to worsening outcomes in patients with acute brain injuries. Transcranial Color-Coded Doppler (TCCD) is a reliable method for evaluating cerebral perfusion and is recommended for use in emergency settings to reduce secondary injuries. However, there is no established treatment protocol for managing cerebral hypoperfusion as detected by TCCD. Objective. The primary objective of this study is to assess the efficacy of individual steps in a standardized treatment protocol to normalize TCCD parameters in patients with cerebral hypoperfusion. The secondary objective is to investigate the concordance between invasive intracranial pressure (ICP) measurements and those estimated through TCCD using the Czosnyka formula. Methods. This prospective multicenter observational study will enroll patients with acute brain injury admitted in emergency or intensive care settings. Inclusion criteria include age over 18, Glasgow Coma Scale \<9, and evidence of cerebral hypoperfusion based on TCCD performed on M1 tract of at least one middle cerebral artery. The hypoperfusion is defined as the concurrent presence of at least two of the following parameters: mean velocity below 30 cm/s, diastolic velocity below 20 cm/s, pulsatility index above 1.4. Patients will undergo a stepwise treatment approach involving normocapnia verification, autoregulation testing increasing mean arterial pressure by 10 mmHg, and hyperosmolar therapy. The effectiveness of each intervention will be assessed by TCCD readings. Endpoints. The primary endpoint is the percentage of patients who normalize cerebral perfusion parameters at each step of the protocol. The secondary endpoint is the concordance between invasive ICP measurements and those estimated through TCCD. Sample Size. The study aims to recruit 100 patients over 24 months. Data analysis will include descriptive statistics, with significant results considered at p \< 0.05.

Interventions

DIAGNOSTIC_TESTTranscranial Color-Coded Doppler (TCCD)

As part of the clinical practice, the examination will be performed with ultrasound machines that have presets for TCCD, using a low-frequency sector probe (2-25 MHz) with a transtemporal approach to obtain a scan through the midbrain plane. Through the use of Color Doppler and Pulsed-Wave Doppler, a spectral doppler waveform of the M1 segment of the middle cerebral artery velocity is obtained bilaterally. If hypoperfusion signs are discovered, TCCD will be repeated to assess the effects of each intervention.

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Patients with intraparenchymal cerebral hemorrhage, subarachnoid hemorrhage, head trauma, or hydrocephalus * Glasgow Coma Scale belowe 9 * Need for invasive mechanical ventilation * Arterial catheter for invasive blood pressure monitoring and blood sampling * Presence of Doppler parameters of cerebral hypoperfusion (concurrent presence of two or more of the following conditions: PI \> 1.4, diastolic velocity \< 20 cm/s, and mean velocity \< 30 cm/s detected in at least one middle cerebral artery)

Exclusion criteria

* Absence of transtemporal windows bilaterally on TCCD * Documented severe aortic valve insufficiency * Heart rate less than 40 bpm * Patients with suspected vasospasm on TCCD

Design outcomes

Primary

MeasureTime frameDescription
TCCD normalization1 hourTo assess the percentage of patients who normalize TCCD cerebral perfusion parameters at each step of the protocol

Secondary

MeasureTime frameDescription
ICP concordance1 hourTo calculate the concordance coefficients between invasively measured ICP values and those obtained through TCCD using the Czosnyka formula

Countries

Italy

Contacts

Primary ContactAnselmo Caricato
anselmo.caricato@policlinicogemelli.it+390630153185

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026